PlanningRegister.ie
South Dublin County Council · SD23A/0123

Grange Castle Business Park, Nangor Road, Clondalkin, Dublin 22

  1. 31 May 2023Received
  2. 17 Jul 2023Grant permission
  3. 25 Aug 2023Final grant
  4. 30 Dec 2025Commenced
  5. 24 Aug 2028Permission expires
Applications only for this county. Appeals, zoning, RZLT and consultations: Dún Laoghaire-Rathdown and Fingal only for now.
Status
Commenced
Decision
Grant permission · 17 Jul 2023
Council
South Dublin County Council
Type
Permission
Site
35.32 ha

What’s proposed

Permission for development consisting of the completion of the development granted permission under Planning Application Reg. Ref. SD16A/0236 subject to the amendments and alterations to the previously approved biopharmaceutical manufacturing facility and warehouse extension and other additional, new development not forming part of SD16A/0236, located at the Pfizer site at Grange Castle Business Park, New Nangor Road; The modifications to the approved development will consist of alterations and modifications to previously approved site buildings and infrastructure required to support the proposed development they include, (a) A 6-level biopharmaceutical manufacturing building sized approximately 30,469sq.m (previously approximately 34,650sq.m) and approximately 35 metres high (previously approximately 28.2m high), with stairwells approximately 38m high, and roof-mounted plant and equipment, including solar panels; Modifications to the existing Development and Manufacturing Facility including elevational alterations and modifications to existing plant and equipment; (b) A single-storey warehouse building extension with high-bay, sized approximately 3,200 square metres (previously approximately 1,142sq.m) and approximately 17.5m high, with roof-mounted plant and equipment, including solar panels; (c) A single-storey pedestrian and materials link sized approximately 1,687sq.m (previously approximately 750sq.m) and approximately 6.95m high; (d) A new, additional 4-level extension to the existing DS1 biopharmaceutical manufacturing building, to accommodate material lifts and storage areas, sized approximately 1,925sq.m and approximately 38.2m high, to the south elevation of the existing building; (e) A new, additional single-storey chiller building sized approximately 395 square metres and approximately 6.25m high, with roof-mounted plant and equipment; (f) A new, additional single-storey plant and utilities building sized approximately 256sq.m and approximately 6.25m high, with roof-mounted plant and equipment; (g) Provision of relocated car park from its previously permitted location at the northeast of the side to a new location to the southeast of the proposed biopharmaceutical facility; including approximately 273 additional car parking spaces, including accessible car parking spaces, electric vehicle charging, motorcycle parking, dedicated car-pooling spaces and cycle parking, all accessed from the internal Grange Castle Business Park roads. Mobility parking is located adjacent and directly north of the proposed facility; (h) A relocated, single-storey security building sized approximately 60 sq.m and 6m high; (i) The proposed site infrastructure includes additional cooling towers/heat exchangers, a tank farm, pipe-bridges, surface water harvest tanks, docks and yard areas, including associated items of plant and equipment, an electric vehicle charging and solar panel substation to service photovoltaic panels over new car parking spaces, photovoltaic solar panels located over new car parking spaces, electrical generators, underground pumping facilities and internal roads and paths, fencing and site lighting, and the use of the existing Pfizer site entrance (Gate No.3) for heavy goods vehicles; (j) The development includes modifications to and the extension of, the existing internal road network within the Pfizer Campus; (k) Proposed new landscaping includes new landscaped and planted areas, replacement and reinforcement of the existing landscaping and modifications to existing berms and perimeter security fencing and gates; (l) Proposed new signage based at ground level and on the building facades on the proposed new production building; (m) The works include temporary contractor compounds, temporary car parking and the temporary use of existing site entrances during construction activities; (n) Proposed new surface water management infrastructure for the site, consisting of underground attenuation systems, rainwater harvest cisterns and distribution pipework; (o) All associated site works including sustainability features described in points (a) to (I); Planning permission for the construction of a temporary contractors car park on land to the west of the Pfizer facility with access off Grange Castle Business Park and the reinstatement of the lands to agriculture after the need for the car park expires; The application is seeking permission of 5 years for the completion of the development granted permission under PA Ref: SD16A/0236 subject to the above amendments and alterations to the previously approved Biopharmaceutical Manufacturing Facility and Warehouse and other additional, new, development not forming part of SD16A/0236; This application consists of a development for an activity for which a licence under Part IV of the Environmental Protection Agency Act 1992 (as amended by the Protection of the Environment Act, 2003) is required; An Environmental Impact Assessment Report (EIAR) accompanies this planning application

SD23A/0123 is a planning application to South Dublin County Council for permission for development consisting of the completion of the development granted, received on 31 May 2023; permission was granted on 17 Jul 2023.

Planning details

Reference
SD23A/0123
Local authority
South Dublin County Council
Status
Commenced · register status “Final Grant
Received
31 May 2023
Observations close
5 Jul 2023 (closed 1167 days ago)
Decision due
25 Jul 2023 · decided 17 Jul 2023
Decision
Grant permission on 17 Jul 2023
Proposed development
Permission for development consisting of the completion of the development granted permission under Planning Application Reg. Ref. SD16A/0236 subject to the amendments and alterations to the previously approved biopharmaceutical manufacturing facility and warehouse extension and other additional, new development not forming part of SD16A/0236, located at the Pfizer site at Grange Castle Business Park, New Nangor Road; The modifications to the approved development will consist of alterations and modifications to previously approved site buildings and infrastructure required to support the proposed development they include, (a) A 6-level biopharmaceutical manufacturing building sized approximately 30,469sq.m (previously approximately 34,650sq.m) and approximately 35 metres high (previously approximately 28.2m high), with stairwells approximately 38m high, and roof-mounted plant and equipment, including solar panels; Modifications to the existing Development and Manufacturing Facility including elevational alterations and modifications to existing plant and equipment; (b) A single-storey warehouse building extension with high-bay, sized approximately 3,200 square metres (previously approximately 1,142sq.m) and approximately 17.5m high, with roof-mounted plant and equipment, including solar panels; (c) A single-storey pedestrian and materials link sized approximately 1,687sq.m (previously approximately 750sq.m) and approximately 6.95m high; (d) A new, additional 4-level extension to the existing DS1 biopharmaceutical manufacturing building, to accommodate material lifts and storage areas, sized approximately 1,925sq.m and approximately 38.2m high, to the south elevation of the existing building; (e) A new, additional single-storey chiller building sized approximately 395 square metres and approximately 6.25m high, with roof-mounted plant and equipment; (f) A new, additional single-storey plant and utilities building sized approximately 256sq.m and approximately 6.25m high, with roof-mounted plant and equipment; (g) Provision of relocated car park from its previously permitted location at the northeast of the side to a new location to the southeast of the proposed biopharmaceutical facility; including approximately 273 additional car parking spaces, including accessible car parking spaces, electric vehicle charging, motorcycle parking, dedicated car-pooling spaces and cycle parking, all accessed from the internal Grange Castle Business Park roads. Mobility parking is located adjacent and directly north of the proposed facility; (h) A relocated, single-storey security building sized approximately 60 sq.m and 6m high; (i) The proposed site infrastructure includes additional cooling towers/heat exchangers, a tank farm, pipe-bridges, surface water harvest tanks, docks and yard areas, including associated items of plant and equipment, an electric vehicle charging and solar panel substation to service photovoltaic panels over new car parking spaces, photovoltaic solar panels located over new car parking spaces, electrical generators, underground pumping facilities and internal roads and paths, fencing and site lighting, and the use of the existing Pfizer site entrance (Gate No.3) for heavy goods vehicles; (j) The development includes modifications to and the extension of, the existing internal road network within the Pfizer Campus; (k) Proposed new landscaping includes new landscaped and planted areas, replacement and reinforcement of the existing landscaping and modifications to existing berms and perimeter security fencing and gates; (l) Proposed new signage based at ground level and on the building facades on the proposed new production building; (m) The works include temporary contractor compounds, temporary car parking and the temporary use of existing site entrances during construction activities; (n) Proposed new surface water management infrastructure for the site, consisting of underground attenuation systems, rainwater harvest cisterns and distribution pipework; (o) All associated site works including sustainability features described in points (a) to (I); Planning permission for the construction of a temporary contractors car park on land to the west of the Pfizer facility with access off Grange Castle Business Park and the reinstatement of the lands to agriculture after the need for the car park expires; The application is seeking permission of 5 years for the completion of the development granted permission under PA Ref: SD16A/0236 subject to the above amendments and alterations to the previously approved Biopharmaceutical Manufacturing Facility and Warehouse and other additional, new, development not forming part of SD16A/0236; This application consists of a development for an activity for which a licence under Part IV of the Environmental Protection Agency Act 1992 (as amended by the Protection of the Environment Act, 2003) is required; An Environmental Impact Assessment Report (EIAR) accompanies this planning application
As published by the register.
Site area
35.32 ha from the mapped boundary, not the council's figure
Applicant
Not published — the national feed carries no applicant name council register

Around this site this application first, then everything within 500 m

Explore from hereFree report
Click a dot to open its row.
Loading planning applications…
Free · during launch · limited time

Full planning report for 53.32433, -6.43511

Zoning, appeals, sold prices, flood and heritage constraints — everything for this area in one PDF.

No account, no payment. Not a statutory planning search.

Appeal

Not appealed.

Commencement

  • Commencement notice CN0136960SD
    30 Dec 2025Grange Castle Business Park. Nangor Road. Dublin 22, Dublin, South Dublinmatched by ref_exact
  • Commencement notice CN0116637SD
    1 Jul 2024Old Nangor Road, Dublin, South Dublinmatched by ref_exact
  • Seven day notice SN0010313SD
    6 May 2024Nangor Road Old, Dublin, South Dublin, D22 V8F8matched by ref_exact
  • Commencement notice CN0107877SD
    30 Nov 2023South Dublin, D22 V8F8matched by ref_exact
  • Seven day notice SN0009046SD
    5 Sept 2023Grange Castle Business Park Nangor Road, Dublin 22, South Dublinmatched by ref_exact

Zoning at the site

C2.1 — Economic development and employment

EE: To provide for enterprise and employment related uses

Zoned for employment uses. Housing is not the intended use here.

Designations within 250 m

No OPW flood extent nearby.

  • EPA-licensed facility · 2
    Pfizer Ireland Pharmaceuticals; P1191
  • Natural Heritage Area (incl. proposed) · 1
    Grand Canal
  • NIAH-recorded building · 1
    Grange Castle
  • Radon risk area · 1
    About 1 in 20 homes in this area is likely to have high radon levels
  • Recorded monument · 8
    Castle - tower house; Castle - unclassified; Barrow - ring-barrow

Provenance

Register row from the national planning applications feed (NPAD), fetched 11 Sept 2026, 18:51 (store id 121227). Deadlines were computed by the store from the received / decided dates under the Planning and Development Act 2000 and are recorded as events, not recomputed here. Council register: https://planning.agileapplications.ie/southdublin/application-details/64295.

Source: npad · fetched 11 Sept 2026, 18:51
SourceLicenceFetchedLink
npadCC-BY-4.011 Sept 2026, 18:51open